TOKYO, September 28, 2018 /PRNewswire/ --
First oral presentation of Quality of Life data from the phase III trial (MAVORIC), the
Growth Capitalist (https://growthcapitalist.com/2018/09/kyowa-kirin-presents-data-at-eortc-cutaneous-lymphoma-task-force-meeting-showing-significantly-improved-quality-of-life-for-patients-with-mycosis-fungoides-mf-and-sezary-syndrome-ss-on-mogamulizum/)
TOKYO, September 28, 2018 /PRNewswire/ --
First oral presentation of Quality of Life data from the phase III trial (MAVORIC), the